In teratoma, hsa-miR-200b-3p prominently targets CDK1 and other key oncogenes, exerting control over PI3K/AKT, MAPK/ERK, Wnt/β-catenin, and Hippo signaling. The gene discussed is AKT1; the disease is teratoma.